Chronic intermittent mechanical stress increases MUC5AC protein expression.
Increased abundance of mucin secretory cells is a characteristic feature of the epithelium in asthma and other chronic airway diseases. We showed previously that the mechanical stresses of airway constriction, both in the intact mouse lung and a cell culture model, activate the epidermal growth factor receptor (EGFR), a known modulator of mucin expression in airway epithelial cells. Here we tested whether chronic, intermittent, short-duration compressive stress (30 cm H(2)O) is sufficient to increase the abundance of MUC5AC-positive cells and intracellular mucin levels in human bronchial epithelial cells cultured at an air-liquid interface. Compressive stress applied for 1 hour per day for 14 days significantly increased the percentage of cells staining positively for MUC5AC protein (22.0 +/- 3.8%, mean +/- SD) relative to unstimulated controls (8.6 +/- 2.6%), and similarly changed intracellular MUC5AC protein levels measured by Western and slot blotting. The effect of compressive stress was gradual, with significant changes in MUC5AC-positive cell numbers evident by Day 7, but required as little as 10 minutes of compressive stress daily. Daily treatment of cells with an EGFR kinase inhibitor (AG1478, 1 muM) significantly but incompletely attenuated the response to compressive stress. Complete attenuation could be accomplished by simultaneous treatment with the combination of AG1478 and a transforming growth factor (TGF)-beta(2) (1 microg/ml)-neutralizing antibody, or with anti-TGF-beta(2) alone. Our findings demonstrate that short duration episodes of mechanical stress, representative of those occurring during bronchoconstriction, are sufficient to increase goblet cell number and MUC5AC protein expression in bronchial epithelial cells in vitro. We propose that the mechanical environment present in asthma may fundamentally bias the composition of airway epithelial lining in favor of mucin secretory cells.
Park
Jin-Ah
JA
Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, 665 Huntington Ave., SPH1-309, Boston, MA 02115, USA.
Tschumperlin
Daniel J
DJ
D001980:Bronchi / Q000166:cytology / Q000378:metabolism*; D016084:Bronchoconstriction / Q000502:physiology*; D002478:Cells, Cultured / Q000378:metabolism; D004847:Epithelial Cells / Q000378:metabolism; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000502:physiology; D051858:Forkhead Transcription Factors / Q000096:biosynthesis / Q000235:genetics; D005786:Gene Expression Regulation / Q000502:physiology*; D051542:Hepatocyte Nuclear Factor 3-beta / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D008868:Microtubule Proteins / Q000096:biosynthesis / Q000235:genetics; D055271:Mucin 5AC / Q000096:biosynthesis* / Q000235:genetics; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011799:Quinazolines; D013314:Stress, Mechanical; D014158:Transcription, Genetic / Q000502:physiology; D053781:Transforming Growth Factor beta2 / Q000494:pharmacology / Q000502:physiology; D020032:Tyrphostins / Q000494:pharmacology
C496502:FOXA2 protein, human; C106349:FOXJ1 protein, human; D051858:Forkhead Transcription Factors; C524678:MUC5AC protein, human; D008868:Microtubule Proteins; D055271:Mucin 5AC; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D053781:Transforming Growth Factor beta2; D020032:Tyrphostins; C044103:tektins; D051542:Hepatocyte Nuclear Factor 3-beta; C101044:RTKI cpd; C512478:EGFR protein, human; D066246:ErbB Receptors